LSV Asset Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.2M Buy
402,400
+389,400
+2,995% +$14M 0.02% 398
2026
Q1
$460K Buy
+13,000
New +$529K ﹤0.01% 714
2013
Q4
Sell
-71,089
Closed -$2.42M 898
2013
Q3
$2.42M Buy
71,089
+20,789
+41% +$678K 0.01% 543
2013
Q2
$1.57M Buy
+50,300
New +$1.63M ﹤0.01% 595

Other funds holding CNMD

LSV Asset Management's CNMD Position: Q2 2026 in Review

LSV Asset Management increased its CONMED (CNMD) stake by 2,995% in Q2 2026, buying an estimated $14M and bringing the position to 402,400 shares worth $13.2M. The position accounts for 0.02% of the portfolio, ranked #398.

LSV Asset Management first reported a position in CNMD in Q2 2013 and has held it in 4 quarters since. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • LSV Asset Management held 402,400 shares of CONMED worth $13.2M as of Q2 2026.
  • LSV Asset Management bought 389,400 CONMED shares in Q2 2026, an estimated $14M.
  • CONMED made up 0.02% of LSV Asset Management's portfolio in Q2 2026, its #398 holding.
  • LSV Asset Management first reported a position in CONMED in Q2 2013 and has held it in 4 quarters since.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on LSV Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.